Early Drug Development Programs: The Need for Translational Medicine and Proven Regulatory Strategies - Clinilabs Drug Development Corporation

Early Drug Development Programs: The Need for Translational Medicine and Proven Regulatory StrategiesJeanine Falinski2023-04-17T18:38:37-04:00

Early Drug Development Programs: The Need for Translational Medicine and Proven Regulatory Strategies

Attendees will gain an understanding of:

The role of translational medicine in a drug development program
The ways in which preparation plays a role in a successful IND package and pre-IND meeting
And more!

This webinar aired live on Wednesday, September 9th, 2020 at 1:00 pm EST. Complete the form below to access the recording.